Prevention of influenza: recommendations for influenza immunization of children, 2006-2007

    Pediatrics
    |April 4, 2007
    PubMed

    Insights

    Annual influenza immunization is recommended for children aged 6 months and older, including healthy children and those with high-risk conditions, for the 2006-2007 season.

    Area of Science:

    • Pediatrics
    • Immunology
    • Public Health

    Background:

    • Influenza poses a significant health risk to children.
    • Previous recommendations for pediatric influenza vaccination have been established.

    Purpose of the Study:

    • To provide updated recommendations for the routine use of influenza vaccine in children for the 2006-2007 influenza season.
    • To guide pediatricians and public health officials on optimal influenza prevention strategies.

    Main Methods:

    • Review of current influenza epidemiology and vaccine efficacy data.
    • Consultation with the Committee on Infectious Diseases.

    Main Results:

    • Annual influenza immunization is recommended for children aged 6-59 months.
    • Children with high-risk conditions aged 6 months and older should receive the vaccine.
    • Household contacts and caregivers of at-risk children and healthy young children are also recommended for immunization.
    • Healthcare professionals should receive annual influenza vaccination.

    Conclusions:

    • The updated recommendations aim to reduce the burden of influenza in pediatric populations.
    • Widespread vaccination is crucial for community protection against influenza.
    • Adherence to these guidelines will enhance influenza prevention efforts in children.

    Related Concept Videos

    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
    Vaccinations01:51

    Vaccinations

    Overview
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
    Pneumonia V: Nursing management and Prevention01:30

    Pneumonia V: Nursing management and Prevention

    Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
    The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
    Enhance airway patency
    Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
    Smallpox01:24

    Smallpox

    Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
    Transmission-based Precautions II: Airborne and Protective Environment01:25

    Transmission-based Precautions II: Airborne and Protective Environment

    Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
    Airborne precautions:
    Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...